Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1/A Registration statement (foreign)
- 3.1 Exhibit 3.1
- 3.2 Exhibit 3.2
- 3.3 Exhibit 3.3
- 3.5 Exhibit 3.5
- 4.1 Exhibit 4.1
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.7 Exhibit 10.7
- 10.12 Exhibit 10.12
- 10.35 Exhibit 10.35
- 10.36 Exhibit 10.36
- 10.37 Exhibit 10.37
- 14.1 Exhibit 14.1
- 23.1 Exhibit 23.1
Associated filings
- 14 Aug 20 424B4 Prospectus supplement with pricing info
- 14 Aug 20 EFFECT Notice of effectiveness
- 10 Aug 20 F-1/A Registration statement (foreign) (amended)
- 7 Aug 20 F-1/A Registration statement (foreign) (amended)
-
31 Jul 20 F-1/A Registration statement (foreign) (amended)
- 24 Jul 20 F-1 Registration statement (foreign)
CVAC similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 29, 2020, with respect to the consolidated financial statements of CureVac AG, included in Amendment No. 1 to the Registration Statement (Form F-1 No. 333-240076) and related Prospectus of CureVac B.V. for the registration of its common shares.
/s/ Dr. Elia Napolitano | /s/ Steffen Maurer |
Wirtschaftsprüfer | Wirtschaftsprüfer |
(German Public Auditor) | (German Public Auditor) |
Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft
Munich, Germany
July 31, 2020